Baraldi M, Zeneroli ML (1982) Experimental hepatic encephalopathy: Changes in the binding of -y-aminobutyric acid. Science 216:427-428. https://doi.org/10.1126/science.6280279
Bleck TP, Smith MC, Pierre-Louis SJ, Jares JJ, Murray J, Hansen CA (1993) Neurologic complications of critical medical illnesses. Crit Care Med 21(1): 98–103. https://doi.org/10.1097/00003246-199301000-00019
Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26(Suppl. 1):64–74. https://doi.org/10.1007/s001340051121
Dal-Pizzol F, Tomasi CD, Ritter C (2014) Septic encephalopathy: does inflammation drive the brain crazy? Braz J Psychiatr 36(3):251-258. https://doi.org/10.1590/1516-4446-2013-1233
Ferenci P, Schafer DF, Kleinberger G, Hoofnagle JH, Jones EA. Serum levels of gamma-aminobutyric acid-like activity in acute and chronic hepatocellular disease. Lancet 1983; 2: 811-814. https://doi.org/10.1016/s0140-6736(83)90735-3
Hamed SA, Hamed EA, Zakary MM (2009) Oxidative stress and S-100B protein in children with bacterial meningitis. BMC Neurol 9:51. https://doi.org/10.1186/1471-2377-9-51
Hellstrom IC, Danik M, Luheshi GN, Williams S (2005) Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus 15:656–664. https://doi.org/10.1002/hipo.20086
Hsu DZ, Liu MY (2004) Bicuculline methiodide attenuates hepatic injury and decreases mortality in septic rats: role of cytokines. Shock 22(4):347-50. https://doi.org/10.1097/01.shk.0000136705.33995.bd
Isgrò MA, Bottoni P, Scatena R (2015) Neuron-specific enolase as a biomarker: Biochemical and clinical aspects. Adv Exp Med Biol 867:125-143. https://doi.org/10.1007/978-94-017-7215-0_9
Jacob A, Brorson JR, Alexander JJ (2011) Septic encephalopathy: inflammation in man and mouse. Neurochem Int 58(4): 472-476. https://doi.org/10.1016/j.neuint.2011.01.004
Jones EA, Schafer DF, Ferenci, Pappas SC (1984) The neurobiology of hepatic encephalopathy. Hepatology 4:1235-1242. https://doi.org/10.1002/hep.1840040624
Kadoi Y, Saito S (1996) An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit Care Med 24(2):298-305. https://doi.org/10.1097/00003246-199602000-00020
Kox M, Pompe JC, Gordinou de Gouberville MC (2011) Effects of the a7 nicotinic acetylcholine receptor agonist gts-21 on the innate immune response in humans. Shock 36:5-11. https://doi.org/10.1097/shk.0b013e3182168d56
Kruijff S, Bastiaannet E, Kobold AC, van Ginkel RJ, Suurmeijer AJ, Hoekstra HJ (2011) S-100B concentrations predict disease-free survival in stage III melanoma patients. Ann Surg Oncol 2009; 16(12): 3455-3462. Erratum in Ann Surg Oncol 18 Suppl 3:S331. https://doi.org/10.1245/s10434-009-0629-8
Li Y, King MA, Meyer EM (2000) Alpha7 nicotinic receptor-medicated protection against ethanol-induced oxidative stress and cytotoxicity in PC12 cells. Brain Res 61:165–167. https://doi.org/10.1016/s0006-8993(99)02457-9
Loop T, Humar M, Pischke S, Hoetzel A, Schmidt R, Pahl HL, Geiger KK, Pannen BH (2003) Thiopental inhibits tumor necrosis factor a–induced activation of nuclear factor B through suppression of IB kinase activity. Anesthesiology 99:360–367. http://doi.org/10.1097/00000542-200308000-00017
Martins PS, Kallas EG, Neto MC (2003) Upregulation of reactive oxygenspecies generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock 20:208–212. https://doi.org/10.1017/S0317167100027128
Minuk GY, Winder A, Burges D, Sarjeant EJ (1985) Serum gammaaminobutyric acid (GABA) levels in patients with hepatic encephalopathy. Hepatogastroenterology 37:171-174. https://doi.org/10.1017/S0317167100027128
Munford RS. Sepsis, severe sepsis and septic shock (2005) In, Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone 906-926.
New KJ, Eaton S, Elliott KRF, Spitz L, Quant PA (2001) Effect of lipopolysaccharide and cytokines on oxidative metabolism in neonatal rat hepatocytes. J Pediatr Surg 36:338–340. https://doi.org/10.1053/jpsu.2001.20710
Olsen RW, Ban M, Miller T (1976) Studies on the neuropharmacological activity of bicuculline and related compounds. Brain Res 102: 283–299. https://doi.org/10.1016/0006-8993(76)90883-0
Ramírez-Jarquín UN, Tapia (2017). Chronic GABAergic blockade in the spinal cord in vivo induces motor alterations and neurodegeneration. Neuropharmacology 117: 85-92. https://doi.org/10.1016/j.neuropharm.2017.01.040
Rossi S, Muzio L, De Chiara V, Grasselli G, Musella A, Musumeci G, Mandolesi G, De Ceglia R, Maida S, Biffi E, Pedrocchi A, Menegon A, Bernardi G, Furlan R, Martino G, Centonze D (2011) Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav Immun 25:947–956. https://doi.org/10.1016/j.bbi.2010.10.004
Sallam MY, El-Gowilly SM, Abdel-Galil AG, El-Mas MM (2006) Central GABAA receptors are involved in inflammatory and cardiovascular consequences of endotoxemia in conscious rats. Naunyn Schmiedebergs Arch Pharmacol 389(3):279-288. https://doi.org/10.1007/s00210-015-1201-7
Serantes R, Arnalich F, Figueroa M, Salinas M, Andrés-Mateos E, Codoceo R, Renart J, Matute C, Cavada C, Cuadrado A, Montiel C (2006) Interleukin-1β enhances GABAA receptor cell surface expression by a phosphatidylinositol 3-kinase/Akt pathway relevance to sepsisassociated encephalopathy. J Biol Chem 281: 14632–14643. https://doi.org/10.1074/jbc.m512489200
Shimohama S, Akaike A, Kimura J. Nicotine-induced protection against glutamate cytotoxicity (1996) Nicotinic cholinergic receptor-medicated inhibition of nitric oxide formation. Ann NY Acad Sci 777:356–361. https://doi.org/10.1111/j.1749-6632.1996.tb34445.x
Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, Hinshaw LB (1990). Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 18(8):801–806. https://doi.org/10.1097/00003246-199008000-00001
Sugiura S, Ishihara Y, Komatsu T, Hagiwara M, Tanigawa N, Kato Y, Mizutani H, Kawahara K, Maruyama I, Noguchi T, Matsushita K (2011). Valproic acid increases susceptibility to endotoxin shock through enhanced release of high-mobility group box 1. Shock 36:494–500. https://doi.org/10.1097/shk.0b013e31822f7e58
Szabo C, Wu CC, Gross SS, Thiemermann C, Vane JR (1993) Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur J Pharmacol 250:157–160. https://doi.org/10.1016/0014-2999(93)90634-T
Takezawa J, Taenaka N, Nishijima MK (1983) Amino acids and thiobarbituric acid reactive substances in cerebrospinal fluid and plasma of patients with septic encephalopathy. Crit Care Med 11:876–879. https://doi.org/10.1097/00003246-198311000-00007
Thiemermann C, Wu CC, Szabo C, Perretti M, Vane JR (1993) Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol 110:177–182. https://doi.org/10.1111/j.1476-5381.1993.tb13789.x
Thomsen MS, Mikkelsen JD (2012) The a7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide- induced TNF-a release from microglia. J Neuroimmunol 251:65-72. https://doi.org/10.1016/j.jneuroim.2012.07.006
Tran DD, Groeneveld AB, van der Meulen J, Nauta JJ, Strack van Schijndel RJ, Thijs LG (1990) Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 18(5):474–479. https://doi.org/10.1097/00003246-199005000-00002
Wang DS, Zurek AA, Lecker I, Yu J, Abramian AM, Avramescu S, Davies PA, Moss SJ, Lu WY, Orser BA (2012) Memory deficits induced by inflammation are regulated by a5-subunit-containing GABAA receptors. Cell Rep 2:488-496. https://doi.org/10.1016/j.celrep.2012.08.022
Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384–388. https://doi.org/10.1038/nature01339
Weigand MA, Volkmann M, Schmidt (2000) Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology 2000; 92(3): 905-907. https://doi.org/10.1097/00000542-200003000-00057
Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR (2010) Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery 148:444–452. https://doi.org/10.1016/j.surg.2010.03.010
Winder TR, Minuk GY, Sargeant EJ, Seland TP (1988) Gamma-Aminobutyric acid (GABA) and sepsis-related encephalopathy. Can J Neurol Sci 15(1):23-25. https://doi.org/10.1017/S0317167100027128
Yao B, Zhang LN, Ai YH, Liu ZY, Huang L (2014) Serum S100beta is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res 39(7):1263-1269. https://doi.org/10.1007/s11064-014-1308-0
Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA (1990) The encephalopathy associated with septic illness. Clin Invest Med 13(6):297–304. PMID: 2078909